What is the recommended CT scan protocol for evaluating adrenal glands with contrast, considering renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CT Protocol for Adrenal Gland Evaluation with Contrast

For adrenal gland evaluation, perform an unenhanced CT first (measuring Hounsfield units), followed by contrast-enhanced CT with delayed imaging at 15 minutes if the initial unenhanced scan shows attenuation >10 HU, as this protocol achieves >95% sensitivity and >97% specificity for distinguishing benign from malignant lesions. 1

Initial Imaging Protocol

Step 1: Unenhanced CT Abdomen and Pelvis

  • Always begin with unenhanced (non-contrast) CT to measure baseline attenuation 1
  • Measure Hounsfield units (HU) using region of interest over the adrenal lesion 1
  • If attenuation ≤10 HU: the lesion is highly specific for adenoma (96-100% specificity), and no further imaging is needed 1
  • If attenuation >10 HU: proceed to contrast-enhanced protocol with delayed washout imaging 1

Step 2: Contrast-Enhanced CT with Delayed Washout (if HU >10)

  • Administer IV contrast and obtain immediate post-contrast images 1
  • Obtain delayed images at 15 minutes post-contrast (some protocols use 30 minutes, but 15 minutes achieves sensitivity >95%, specificity >97%) 1
  • Calculate contrast washout: adenomas wash out >60% at 15 minutes, while malignant lesions retain contrast 1
  • This delayed enhancement technique is superior to unenhanced CT alone and may be superior to MRI 1

Renal Function Considerations

Pre-Contrast Assessment

  • Check current GFR before administering contrast 2
  • GFR >60 mL/min: contrast can be administered with minimal risk 2
  • GFR 30-60 mL/min: implement pre-procedural hydration with isotonic saline, use low-osmolar or iso-osmolar contrast agents, minimize contrast volume 2
  • GFR <30 mL/min: consider MRI with chemical shift imaging or non-contrast alternatives 2

Critical Pitfall to Avoid

  • Never skip the unenhanced phase when evaluating adrenal masses - in one study, unenhanced CT detected parenchymal abnormalities in only 1.4% of cases when performed after contrast, missing critical diagnostic information 1
  • Performing only contrast-enhanced CT without baseline unenhanced images reduces sensitivity for adenoma detection from 56% to approximately 10-36% (even with histogram analysis) 1

Alternative Protocol: Chemical Shift MRI

If the adrenal mass is discovered incidentally on contrast-enhanced CT (no baseline unenhanced images available), chemical shift MRI is the preferred next step rather than repeating CT 1

  • Chemical shift MRI detects lipid content in adenomas with 96-100% accuracy 1
  • Particularly useful when CT density is indeterminate (10-30 HU), where MRI correctly characterizes 89% of lesions 1
  • Avoids additional radiation and contrast exposure 1

Size-Specific Protocols

Lesions <3 cm

  • Unenhanced CT (rating 8/9) or delayed enhancement CT if HU >10 (rating 8/9) 1
  • Chemical shift MRI (rating 8/9) if discovered on contrast-enhanced study 1
  • Follow-up imaging at 6-12 months if indeterminate 1

Lesions 3-5 cm

  • Same protocol as above, but follow-up at 3-6 months if indeterminate 1
  • Biopsy consideration increases (rating 6/9) if non-invasive imaging inconclusive 1

Lesions >4 cm

  • Suspect adrenal carcinoma if >4 cm with irregular margins or internal heterogeneity 1
  • Perform adrenal protocol CT: unenhanced for HU measurement, then contrast-enhanced with 15-minute washout 1
  • If HU >10 and washout <60% at 15 minutes, malignancy is likely 1

Common Pitfalls

  1. Failing to obtain unenhanced images first - this is the single most important error, as it eliminates the ability to accurately measure baseline attenuation 1

  2. Not waiting long enough for delayed images - imaging before 15 minutes reduces sensitivity for distinguishing adenomas from metastases 1

  3. Ignoring renal function before contrast administration - pre-existing renal impairment is the principal risk factor for contrast-induced nephropathy 2, 3

  4. Using histogram analysis incorrectly - if ≥5% of pixels are <0 HU on post-contrast images, sensitivity improves from 10% to 36%, but this still underperforms compared to proper unenhanced imaging 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

CT with Contrast in IgA Nephropathy for Diverticulitis Follow-up

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Tubular Necrosis from Contrast-Induced Nephropathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.